Target intelligence / Profile preview

Cholesterol metabolism pathways in avian reproductive tissues

Molecular classification
Enzyme, Transporter, Transcription factor, Receptor
01

Overview

Cholesterol metabolism pathways in avian reproductive tissues encompass the integrated biochemical processes of cholesterol uptake, de novo synthesis, and conversion into steroid hormones within organs like the ovary and oviduct (Johnson, 2015, Sturkie's Avian Physiology). Cholesterol serves as the essential precursor for steroidogenesis, producing hormones such as estradiol and progesterone that regulate the reproductive cycle and egg formation (PMID: 25595939). In birds, a significant portion of cholesterol is also transported via the blood as specialized very-low-density lipoprotein (VLDLy) to be deposited into the developing oocyte as yolk (PMID: 10604487). Key molecular players in these pathways include the rate-limiting enzyme 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the steroidogenic acute regulatory protein (StAR), and cytochrome P450 side-chain cleavage enzyme (CYP11A1) (PMID: 15607115). While these pathways are vital for avian physiology and are studied in the context of poultry productivity and as models for human ovarian cancer, they represent a broad biological system rather than a single druggable target. Pharmacological modulation of these pathways, for instance with statins, can significantly impact reproductive efficiency and lipid homeostasis (PMID: 17215248).

Other names
Avian steroidogenesis pathwayCholesterol homeostasis in avian ovaryAvian reproductive lipid metabolism
02

Mechanism of action

Modulation of cholesterol availability and conversion through the inhibition of rate-limiting enzymes (e.g., HMGCR, CYP11A1) or transport proteins (e.g., StAR) within the reproductive axis.

03

Biological functions

SteroidogenesisLipid metabolismOogenesisEgg yolk formationCellular cholesterol homeostasis
04

Disease associations

Reproductive dysfunctionFatty liver hemorrhagic syndrome (FLHS)Ovarian cancer (avian model)Dyslipidemia
05

Safety considerations

Reduced egg laying rateImpaired yolk depositionEndocrine disruptionImpaired embryonic developmentSystemic metabolic disruption
06

Interacting drugs

Atorvastatin

4 more in the full profile.

07

Biomarkers

Plasma cholesterol levelsVitellogenin (VTG)Estradiol-17β (E2)Progesterone (P4)Very-low-density lipoprotein (VLDL) concentration

Beyond the preview

Go deeper on Cholesterol metabolism pathways in avian reproductive tissues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cholesterol metabolism pathways in avian reproductive tissues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call